MCRB logo

Seres Therapeutics (MCRB) CAPEX

Annual CAPEX

$7.97 M
-$1.85 M-18.80%

December 31, 2023

Summary

Performance

1-Year Change

-18.8%

3-Year Change

+1249.41%

5-Year Change

+311.72%

15-Year Change

+70.55%

MCRB CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.44%
MCRB annual capital expenditures is higher than 62.44% of companies in Healthcare sector

High & Low

All-time High

$21.49 M
MCRB annual capital expenditures is currently -62.89% below its historical high of $21.49 million

3-Year Low

$7.97 M
MCRB annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MCRB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
MCRB next annual earnings announcement is scheduled for Mar 5, 2025

OtherMCRBcash flowmetrics:

Annual FCF

-$125.33 M
MCRB annual free cash flow is -$125.33 million

Annual CFO

-$117.35 M
MCRB annual cash flow from operations is -$117.35 million

Annual CFI

$10.58 M
MCRB annual cash flow from investing activities is $10.58 million

Annual CFF

$71.70 M
MCRB annual cash flow from financing activities is $71.70 million

Quarterly CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MCRB Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$6.55 M
MCRB quarterly capital expenditures is currently at an all-time high

3-Year Low

$877.00 K
MCRB quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MCRB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
MCRB next earnings announcement is scheduled for Mar 5, 2025

OtherMCRBcash flowmetrics:

Quarterly FCF

-$34.81 M
MCRB quarterly free cash flow is -$34.81 million

Quarterly CFO

-$34.68 M
MCRB quarterly cash flow from operations is -$34.68 million

Quarterly CFI

$141.14 M
MCRB quarterly cash flow from investing activities is $141.14 million

Quarterly CFF

-$110.87 M
MCRB quarterly cash flow from financing activities is -$110.87 million

TTM CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MCRB TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$21.49 M
MCRB TTM capital expenditures is currently at an all-time high

3-Year Low

$7.94 M
MCRB TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MCRB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
MCRB next earnings announcement is scheduled for Mar 5, 2025

OtherMCRBcash flowmetrics:

TTM FCF

-$158.39 M
MCRB TTM free cash flow is -$158.39 million

TTM CFO

-$157.23 M
MCRB TTM cash flow from operations is -$157.23 million

TTM CFI

$141.51 M
MCRB TTM cash flow from investing activities is $141.51 million

TTM CFF

-$85.68 M
MCRB TTM cash flow from financing activities is -$85.68 million

MCRB CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.8%--
3 y3 years+1249.4%--
5 y5 years+311.7%--

MCRB CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.8%at low
5 y5-year-18.8%+1249.4%
alltimeall time-62.9%+1249.4%

Seres Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$7.97 M(-18.8%)
$877.00 K(-51.2%)
$7.97 M(-24.5%)
Sep 2023
-
$1.80 M(+45.7%)
$10.56 M(+5.5%)
Jun 2023
-
$1.23 M(-69.7%)
$10.01 M(-8.5%)
Mar 2023
-
$4.07 M(+17.5%)
$10.94 M(+11.4%)
Dec 2022
$9.82 M(+2.7%)
$3.46 M(+177.5%)
$9.82 M(+23.7%)
Sep 2022
-
$1.25 M(-42.3%)
$7.94 M(-26.4%)
Jun 2022
-
$2.16 M(-26.7%)
$10.78 M(-3.5%)
Mar 2022
-
$2.95 M(+86.9%)
$11.17 M(+16.8%)
Dec 2021
$9.57 M(+1518.6%)
$1.58 M(-61.4%)
$9.57 M(+16.5%)
Sep 2021
-
$4.09 M(+60.2%)
$8.21 M(+96.1%)
Jun 2021
-
$2.55 M(+90.3%)
$4.19 M(+124.9%)
Mar 2021
-
$1.34 M(+493.8%)
$1.86 M(+215.1%)
Dec 2020
$591.00 K(-41.0%)
$226.00 K(+242.4%)
$591.00 K(-0.7%)
Sep 2020
-
$66.00 K(-71.1%)
$595.00 K(-9.0%)
Jun 2020
-
$228.00 K(+221.1%)
$654.00 K(-14.7%)
Mar 2020
-
$71.00 K(-69.1%)
$767.00 K(-23.5%)
DateAnnualQuarterlyTTM
Dec 2019
$1.00 M(-48.3%)
$230.00 K(+84.0%)
$1.00 M(+74.0%)
Sep 2019
-
$125.00 K(-63.3%)
$576.00 K(-38.0%)
Jun 2019
-
$341.00 K(+11.4%)
$929.00 K(-28.0%)
Mar 2019
-
$306.00 K(-256.1%)
$1.29 M(-33.4%)
Dec 2018
$1.94 M(-58.6%)
-$196.00 K(-141.0%)
$1.94 M(-31.3%)
Sep 2018
-
$478.00 K(-31.9%)
$2.82 M(+0.5%)
Jun 2018
-
$702.00 K(-26.3%)
$2.80 M(-17.1%)
Mar 2018
-
$953.00 K(+39.1%)
$3.38 M(-27.7%)
Dec 2017
$4.68 M(-78.2%)
$685.00 K(+47.6%)
$4.68 M(-51.7%)
Sep 2017
-
$464.00 K(-63.7%)
$9.68 M(-35.8%)
Jun 2017
-
$1.28 M(-43.0%)
$15.07 M(-25.9%)
Mar 2017
-
$2.25 M(-60.5%)
$20.34 M(-5.4%)
Dec 2016
$21.49 M
$5.69 M(-2.9%)
$21.49 M(+36.0%)
Sep 2016
-
$5.86 M(-10.5%)
$15.80 M(+58.9%)
Jun 2016
-
$6.55 M(+92.5%)
$9.95 M(+192.5%)
Mar 2016
-
$3.40 M
$3.40 M

FAQ

  • What is Seres Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Seres Therapeutics?
  • What is Seres Therapeutics annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for Seres Therapeutics?
  • What is the all time high TTM CAPEX for Seres Therapeutics?

What is Seres Therapeutics annual capital expenditures?

The current annual CAPEX of MCRB is $7.97 M

What is the all time high annual CAPEX for Seres Therapeutics?

Seres Therapeutics all-time high annual capital expenditures is $21.49 M

What is Seres Therapeutics annual CAPEX year-on-year change?

Over the past year, MCRB annual capital expenditures has changed by -$1.85 M (-18.80%)

What is the all time high quarterly CAPEX for Seres Therapeutics?

Seres Therapeutics all-time high quarterly capital expenditures is $6.55 M

What is the all time high TTM CAPEX for Seres Therapeutics?

Seres Therapeutics all-time high TTM capital expenditures is $21.49 M